Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3
Summary (participants) Number of participants screened
Number of participants included
Number of participants randomly assigned to methylphenidate and control
Number of participants followed up in each arm: methylphenidate and control
Number of withdrawals in each arm: Methylphenidate and control
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM‐III) diagnosis of attention deficit hyperactivity disorder (ADHD) (combined (%), hyperactive‐impulsive (%), inattentive (%))
Age (years) (mean, range)
IQ (mean, range)
Sex (male, female)
Methylphenidate naive (%/number)
Ethnicity (white (%), African American (%), Asian (%), Hispanic (%), other (%))
Country
Comorbidity (type %)
Comedication (no/yes)
Sociodemographics (e.g. double or single parent family, low, middle or upper class)
Inclusion criteria
Exclusion criteria